IntrinsicIntrinsic
OverviewFinancialsChartBusiness SummaryFilingsOwnershipValuation

Recent Updates — CNC

August 17, 2026View Source ↗

Centene Corporation announced that Chief Financial Officer Andrew Asher will step down on December 31, 2026, retiring from the company at the end of 2027 while serving as Strategic Advisor through year-end. Christopher Neczypor has been appointed as his successor, effective January 1, 2027. Neczypor previously served as CFO of Lincoln National Corporation and will join Centene in September 2026 as Executive Vice President. His compensation package includes a $1.1 million base salary, a target bonus of up to 200% of base, $5.25 million in annual long-term equity incentives, a $10 million one-time restricted stock unit grant for forfeited compensation, and a $2 million cash sign-on bonus. The company also reaffirmed its full-year 2026 adjusted diluted earnings per share guidance of greater than $4.80. Centene Corporation operates in the managed care industry, providing government-sponsored and commercial healthcare programs.

July 29, 2026View Source ↗

On July 29, 2026, Centene Corporation delivered a notice to partially redeem $500 million of its outstanding 4.25% Notes due December 15, 2027. The redemption is scheduled for August 13, 2026, at a price equal to 100% of the principal amount plus accrued and unpaid interest. Following this transaction, approximately $568.7 million of the notes will remain outstanding. Centene Corporation operates in the managed healthcare industry, providing health insurance and related services.

July 27, 2026View Source ↗

Centene Corporation reported second quarter 2026 financial results with total revenues of $53.6 billion and GAAP diluted earnings per share of $2.19. The company increased its full-year 2026 GAAP diluted EPS guidance to greater than $3.11 and adjusted diluted EPS guidance to greater than $4.80, citing underlying business strength and approximately $0.50 of non-recurring items. Centene also announced that Director Kenneth Burdick retired from the Board effective July 28, 2026, and Paul Diaz was elected to fill the vacancy. Centene operates in the managed healthcare industry, providing government-sponsored and commercial healthcare programs to under-insured individuals.

June 22, 2026View Source ↗

Centene Corporation increased its Board of Directors from 0 to 10 and elected Lauren Tyler to the Board, with a term expiring at the 2027 annual meeting. Ms. Tyler, a former Executive Vice President at JPMorgan Chase & Co., will serve on the Audit and Compensation and Talent Committees, effective July 1, 2026. Centene Corporation is a healthcare services company providing managed care services.

May 15, 2026View Source ↗

Centene Corporation held its annual meeting on May 12, 2026, where shareholders elected nine directors and approved executive compensation and the appointment of KPMG LLP. A shareholder proposal to appoint an independent board chairman was defeated, receiving 72,839,667 votes in favor and 308,562,931 against. The company also formally designated its executive officer team following recent leadership appointments.

April 28, 2026View Source ↗

Centene Corporation announced its financial results for the first quarter ended March 31, 2026, via a press release issued on April 28, 2026. The filing serves as the formal announcement of these results, though the specific financial figures are contained in the accompanying exhibit rather than the body of the report.